CEP-9722

DB14882InvestigationalSmall molecule

CEP-9722 is under investigation in clinical trial NCT01345357 (Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma).

Mechanism: Pharmacologically active on Poly [ADP-ribose] polymerase 1, Poly [ADP-ribose] polymerase 2, and Poly [ADP-ribose] polymerases
Curator reviewed
Formula / weight: C₂₄H₂₆N₄O₃ · 418.497 g/mol (avg)
Code names: CEP-9722

Resolves to

Compound

UNIIB68083E4YGCAS916574-83-9

Structure

InChIKeyCTLOSZHDGZLOQE-UHFFFAOYSA-NSMILESCOC1=CC=CC2=C1C1=C(N2)C2=C(CCC2)C2=C1C(=O)N(CN1CCN(C)CC1)C2=O

Targets

P09874PARP1Q9UGN5PARP2

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with CEP-9722, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account